Table 2.
Methodological Quality of included studies.
| Study ID | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Webright, W. G. 1997 | Yes | Yes | No | Yes | No | No | No | Yes | Yes | Yes | Yes | 6 |
| Bandy, W. D. 1998 | Yes | Yes | No | Yes | No | No | Yes | Yes | Yes | Yes | Yes | 7 |
| Herman, S. L. 2008 | Yes | Yes | No | Yes | No | No | No | No | No | No | No | 2 |
| O'Sullivan, K. 2009 | Yes | Yes | Yes | Yes | No | No | No | Yes | Yes | Yes | Yes | 7 |
| Amiri-Khorasani, M. 2011 | Yes | No | No | Yes | No | No | No | Yes | Yes | Yes | Yes | 5 |
| Behm, D. G. 2011 | Yes | Yes | Yes | Yes | No | No | No | Yes | Yes | Yes | Yes | 7 |
| Perrier, E. T. 2011 | Yes | No | No | Yes | No | No | No | Yes | Yes | Yes | Yes | 5 |
| Silveira, G. 2011 | Yes | Yes | Yes | Yes | No | No | Yes | Yes | No | Yes | Yes | 7 |
| Samson, M. 2012 | Yes | Yes | Yes | Yes | No | No | No | Yes | Yes | Yes | Yes | 7 |
| Morrin, N. 2013 | Yes | Yes | Yes | Yes | No | No | No | Yes | Yes | Yes | Yes | 7 |
| Chen. 2015 | Yes | Yes | No | Yes | No | No | No | No | No | Yes | Yes | 4 |
| C Kurt. 2015 | Yes | Yes | Yes | Yes | No | No | No | Yes | Yes | Yes | Yes | 7 |
| Chaouachi, A. 2015 | Yes | No | No | Yes | No | No | No | Yes | Yes | Yes | Yes | 5 |
| Su, Hsuan 2016 | Yes | Yes | Yes | Yes | No | No | No | Yes | Yes | Yes | Yes | 7 |
| Matsuo, S. 2019 | Yes | Yes | Yes | Yes | No | No | Yes | Yes | Yes | Yes | Yes | 8 |
| Zhou, Wen Sheng 2019 | Yes | Yes | Yes | Yes | No | No | No | No | No | Yes | Yes | 5 |
| Fakhro, M. A. 2020 | Yes | Yes | Yes | Yes | No | No | Yes | Yes | Yes | Yes | Yes | 8 |
| Ferreira-Junior, Joao B. 2021 | Yes | Yes | No | Yes | No | No | Yes | No | No | Yes | Yes | 5 |
| Lee, Jin Hyuck 2021 | Yes | Yes | Yes | Yes | No | No | Yes | No | No | Yes | Yes | 6 |
| Siebert, T. 2022 | Yes | Yes | Yes | Yes | No | No | No | Yes | Yes | Yes | Yes | 7 |
| Gunaydin, G. 2020 | Yes | Yes | No | Yes | No | No | No | Yes | Yes | Yes | Yes | 6 |
| Vasileiou 2013 | Yes | Yes | Yes | Yes | No | No | No | Yes | Yes | Yes | Yes | 7 |
| Zmijewski, P. 2020 | Yes | Yes | Yes | Yes | No | No | No | Yes | Yes | Yes | Yes | 7 |
| Amber Magner 2012 | Yes | Yes | Yes | Yes | No | No | No | Yes | Yes | Yes | Yes | 7 |
| Philip Ford 2007 | Yes | Yes | No | No | No | No | No | Yes | Yes | Yes | Yes | 5 |
| Jesus López 2013 | Yes | Yes | Yes | Yes | No | No | No | Yes | Yes | Yes | Yes | 7 |
| Cem Kurt 2016 | Yes | Yes | No | Yes | No | No | No | Yes | Yes | Yes | Yes | 6 |
1: eligibility criteria were specified. 2: subjects were randomly allocated to groups. 3: allocation was concealed. 4: the groups were similar at baseline regarding the most important prognostic indicators. 5: there was blinding of all subjects. 6: there was blinding of all therapists. 7: there was blinding of all assessors. 8: measures of at least one key outcome were obtained from more than 85% of the subjects initially allocated to groups. 9: all subjects for whom outcome measures were available received the treatment or control condition as allocated. 10: the results of between-group statistical comparisons are reported for at least one key outcome. 11: the study provides both point measures and measures of variability for at least one key outcome.